dev.PILOTforPulmonary.orgdev.PILOTforPulmonary.orgdev.PILOTforPulmonary.org

 x 

0 Activities
0 Activities
  • No Saved Activities
  • Home
  • Education
    • Top Disease Areas
      • Asthma
      • Bronchiectasis
      • Chronic Obstructive Pulmonary Disease (COPD)
      • COVID-19
      • Idiopathic Pulmonary Fibrosis
      • Interstitial Lung Disease (ILD)
      • Nontuberculous Mycobacteria (NTM)
      • Non-Small Cell Lung Cancer (NSCLC)
      • Pulmonary Hypertension (PH/PAH)
      • Radiology
      • Rheumatoid Conditions
    • Content Type
      • Animation
      • EXPLORE™
      • Interactive Cases
      • Podcast
      • Slides
      • Video
      • Webinar

    Search Education

    Latest Education

    9460-repi3

    Race, Ethnicity & Pulmonary Function Test Interpretation

    9465_263x1494

    Slides: Bronchiectasis Update: Diagnostic Innovations and Therapeutic Frontiers

    9465_263x149

    Bronchiectasis Update: Diagnostic Innovations and Therapeutic Frontiers

    Menu Ad
  • Register
  • Contact Us
  • Login

    Login

    Create an account
    • Forgot your password?

 

Jointly Accredited Provider

Search

  • Credit Type
    • CME (AMA PRA Category 1 Credit)
    • MOC (Maintenance of Certification)
  • Disease Area
    • Alpha-1 Antitrypsin Deficiency (AATD)
    • Asthma
    • Bronchiectasis
    • Chronic Obstructive Pulmonary Disease (COPD)
    • COVID-19
    • Cystic Fibrosis (CF)
    • Idiopathic Pulmonary Fibrosis (IPF)
    • Interstitial Lung Disease (ILD)
    • Non-Small Cell Lung Cancer (NSCLC)
    • Nontuberculous Mycobacteria (NTM)
    • Pulmonary Hypertension (PH/PAH)
    • Radiology
    • Rheumatoid Conditions
  • Content Type
    • Animation
    • EXPLORE™
    • Interactive Cases
    • Podcast
    • Slides
    • Video
    • Webinar

PILOTforPulmonary.org

PILOT provides comprehensive continuing medical education, supporting the diagnosis and management patients for various pulmonary diseases.

  • Start
  • «
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • »
  • End
Page 12 of 15
Results 166 - 180 of 222
rePlace2
Factors Associated with Respiratory Involvement in NTM
rePlace2
Most Common Species in NTM Lung Disease
rePlace2
Nontuberculous Mycobacteria: Introduction and Epidemiology
No image set
New Therapies, New Opportunities and New Challenges in Managing NTM
No image set
Updates in Inoperable CTEPH
pah icon
PAH Today: Mastering Current, Tailored Treatment
No image set
Achieving Better Control of Severe Asthma
asthma-uncontrol icon
A Personalized Approach to Managing Uncontrolled Asthma
Proper_Use_of_an_Inhaler_264x150
Proper Use of an Inhaler
No image set
Nontuberculous Mycobacterial Lung Disease Today and Tomorrow
No image set
Exploring the Patient Journey with Problem-Based Learning
No image set
Genetics and Personalized Medicine for Patients with Pulmonary Fibrosis
No image set
Environmental Influences on the Development of Pulmonary Fibrosis
No image set
Gene Abnormalities and ILD
No image set
Exploring the Basic Mechanisms that Contribute to Development of Lung Fibrosis
  • Start
  • «
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • »
  • End
Page 12 of 15

The France Foundation

A ACCME Accredited provider.

The France Foundation ©

10 Vista Drive, Old Lyme, CT USA

Copyright © 2024 The France Foundation All Rights Reserved.
The France Foundation | Privacy Policy | Terms of Use

Search

  • Home
  • Education
    • Top Disease Areas
      • Asthma
      • Bronchiectasis
      • Chronic Obstructive Pulmonary Disease (COPD)
      • COVID-19
      • Idiopathic Pulmonary Fibrosis
      • Interstitial Lung Disease (ILD)
      • Nontuberculous Mycobacteria (NTM)
      • Non-Small Cell Lung Cancer (NSCLC)
      • Pulmonary Hypertension (PH/PAH)
      • Radiology
      • Rheumatoid Conditions
    • Content Type
      • Animation
      • EXPLORE™
      • Interactive Cases
      • Podcast
      • Slides
      • Video
      • Webinar
  • Register
  • Contact Us
  • Login
This site uses cookies. By continuing to use this website, you agree to their use. For details, please check our Privacy Policy.
I accept